Chromocarbe

CAS No. 4940-39-0

Chromocarbe( Chromocarb )

Catalog No. M14654 CAS No. 4940-39-0

Chromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 38 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Chromocarbe
  • Note
    Research use only, not for human use.
  • Brief Description
    Chromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections.
  • Description
    Chromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections. Peroral treatment of rats with Chromocarb significantly reduces the degradation of the vascular wall by intravenous collagenase. Chromocarb treatment induces a lesser permeability increase of the BBB, a shorter recovery time, lower hydroxyproline levels in the cerebrospinal fluid and a lesser decrease of the collagen content of the brain capillary basal lamina.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Chromocarb
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    4940-39-0
  • Formula Weight
    190.15
  • Molecular Formula
    C10H6O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 38 mg/mL (199.84 mM)
  • SMILES
    O=C(C1=CC(C2=CC=CC=C2O1)=O)O
  • Chemical Name
    4-Oxo-4H-1-benzopyran-2-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Godeau G, et al. Clin Physiol Biochem, 1987, 5(1), 15-26.
molnova catalog
related products
  • Glaucine

    Glaucine has antitussive antioxidative potential and antiviral activities it may be an anti-arthritic agent it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of human breast cancer cells by MMP-9 inhibitory activity attenuating IκBα and NF-κB activities.

  • Coixol

    Coixol acts as a central muscle relaxant with an anti-convulsant effect.

  • Urelumab

    Urelumab(BMS-66513) is a humanized IgG4 monoclonal antibody, often used as a CD137 agonist.